Adjusting the PIVET rFSH Dosing Algorithm for the Biosimilar Bemfola Product

John L Yovich; Peter M Hinchliffe; Sunthra Lingam; Shanthi Srinivasan; Kevin N Keane

నైరూప్య

Adjusting the PIVET rFSH Dosing Algorithm for the Biosimilar Bemfola Product

John L Yovich, Peter M Hinchliffe, Sunthra Lingam, Shanthi Srinivasan and Kevin N Keane

This short-communication introduces the biosimilar product Bemfola into the fold of gonadotrophin hormonal preparations for safe and efficient application in IVF programmes. It enables recombinant follicle stimulating hormone dosage selection on the basis of personal characteristics of the woman undergoing treatment and allows for appropriate variations according to her plans for preimplantation diagnosis or screening, the idea of segmental treatment whereby embryos are vitrified for future FET procedures and the considerations of oocyte banking or oocyte donation. It does not cover considerations of clinical effectiveness although the cited studies indicate Bemfola has similar clinical outcomes to its reference product Gonal-F.

నిరాకరణ: ఈ సారాంశం కృత్రిమ మేధస్సు సాధనాలను ఉపయోగించి అనువదించబడింది మరియు ఇంకా సమీక్షించబడలేదు లేదా ధృవీకరించబడలేదు.